Summer Street Starts Onyx Pharma (ONXX) at Buy, $49 Price Target
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Price: $124.70 --0%
Rating Summary:
9 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 50
Rating Summary:
9 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 50
Join SI Premium – FREE
An analyst at Summer Street initiated coverage on shares of Onyx Pharmaceuticals (NASDAQ: ONXX) with a Buy rating and a $49 price target.
With shares of Onyx up 1.2 percent to around $30.14, Summer Street's new price target implies potential upside of about 63 percent.
For more ratings news on Onyx Pharmaceuticals click here and for the rating history of Onyx Pharmaceuticals click here.
With shares of Onyx up 1.2 percent to around $30.14, Summer Street's new price target implies potential upside of about 63 percent.
For more ratings news on Onyx Pharmaceuticals click here and for the rating history of Onyx Pharmaceuticals click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Upgrades Barry Callebaut AG (BARN:SW) (BYCBF) to Buy
- Evercore ISI Starts Analog Devices (ADI) at Outperform, 'MXIM + LLTC Synergies Imminent'
- William Blair Starts On Holding AG (ONON) at Outperform, 'e see a path to three-year revenue growth above 25%'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
